This page provides a list of selected clinical guidelines related to tuberculosis (TB) topics. Guidelines are sorted by topics: testing and diagnosis, treatment, drug resistance, infection control, TB and HIV, specific populations, and vaccines.
| Title | Year Published |
|---|---|
| Diagnosis of Tuberculosis in Children and Adults Clinical Infectious Disease 2017 Executive Summary Full Guidelines | 2017 |
| Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013 MMWR 2013; 62 (No. 41) | 2013 |
| National Shortage of Purified-Protein Derivative Tuberculin Products MMWR 2013; 62 (No. 16) | 2013 |
| Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis | 2012 |
| Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010 MMWR 2010; 59 (RR-5); 1-25 | 2010 |
| Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis MMWR 2009; 58 (01); 7-10 | 2009 |
| Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States MMWR 2005; 54 (No. RR-15, 49-55) | 2005 |
| Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC MMWR 2005; 54 (No. RR-15, 1-37) | 2005 |
| Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor – Alpha California, 2002–2003 – MMWR 2004; 53 (No. 30) | 2004 |
| Timing of Tuberculosis Screening and Smallpox Vaccination – Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program MMWR 2003; 52 (No. RR-7) | 2003 |
| Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR-6) | 2000 |
| Diagnostic Standards / Classification of TB in Adults and Children Am J Respir Crit Care Med 2000; 161 | 1999 |
| The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. (ACET and ACIP) MMWR 1996; 45 (No. RR-4) | 1996 |
| Title | Year Published |
|---|---|
| Provisional CDC Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease | 2023 |
| Treatment of Drug-Resistant Tuberculosis American Journal of Respiratory and Critical Care Medicine, 2019 Executive Summary Full Guidelines | 2019 |
| Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis MMWR 2013; 62 (No. 9) | 2013 |
| Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013 MMWR 2013; 62 (No. 41) | 2013 |
| Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States | 2008 |
| Plan to Combat Extensively Drug-Resistant Tuberculosis MMWR 2009; 58 (RR-03) | 2009 |
| Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR-6) | 2000 |
MMWR 2005; 54 (No. RR-17)
Reprint
Note: The errata was removed. The corrections included in the errata have been incorporated into the reprinted guidelines. The recommendation for screening, testing, and treatment of U.S. health care personnel were updated in 2019. Please see the above recommendations.
